COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

Detalles Bibliográficos
Autores principales: Paschou, Stavroula A., Karalis, Vangelis, Psaltopoulou, Theodora, Charitaki, Ioanna, Sklirou, Aimilia D., Iconomidou, Vassiliki A., Vasileiou, Vasiliki, Kassi, Georgia N., Vryonidou, Andromachi, Kokkinos, Alexander, Tentolouris, Nicholas, Hatziaggelaki, Erifili, Trougakos, Ioannis P., Terpos, Evangelos, Dimopoulos, Meletios-Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652043/
https://www.ncbi.nlm.nih.gov/pubmed/36369623
http://dx.doi.org/10.1007/s42000-022-00419-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652043/
https://www.ncbi.nlm.nih.gov/pubmed/36369623
http://dx.doi.org/10.1007/s42000-022-00419-1

Ejemplares similares